MedPath

Effects of Low Dose Fentanyl Supplementation of Reduced Dose Propofol during Electroconvulsive Therapy

Phase 3
Completed
Conditions
psychiatric patients who receiving electroconvulsive therapy
Hemodynamic response Propofol
Electroconvulsive therapy
Fentanyl
Thiopental
Seizure duration
Registration Number
TCTR20201127005
Lead Sponsor
Faculty of Medicine, Ramathibodi Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
22
Inclusion Criteria

adults, aged 18-65 years old and scheduled for bilateral ECT treatment.

Exclusion Criteria

patients who had a history of cardiovascular or cerebrovascular disease, poorly controlled hypertension, pregnancy, obesity (body mass index > 30 kg/m2), and had a contraindication to use thiopental, propofol, fentanyl, or succinylcholine.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
seizure duration Pre-dose, 1 min,2 min,3 min,4 min,5 min,6 min,7 min,8 min,9 min,10 min Post-dose EEG,blood pressure in,3 min,4 min,5 min,6 min,7 min,8 min,9 min,10 min Post-dose mmHg,blood pressure Pre-dose, 1,2,3,4,5,6,7,8,9,10 Post-dose mmHg,Oxygen satuaration in,3 min,4 min,5 min,6 min,7 min,8 min,9 min,10 min Post-dose pulse oxymeter ,heart rate in,3 min,4 min,5 min,6 min,7 min,8 min,9 min,10 min Post-dose EKG
Secondary Outcome Measures
NameTimeMethod
BIS index in,3 min,4 min,5 min,6 min,7 min,8 min,9 min,10 min Post-dose BIS
© Copyright 2025. All Rights Reserved by MedPath